The Aftermath of Hepatitis C Drugs on Specialty Spending

Video

David Lassen, chief clinical officer at Prime Therapeutics, discusses how high cost hepatitis C drugs have impacted the entire specialty landscape.

David Lassen, chief clinical officer at Prime Therapeutics, discusses how high cost hepatitis C drugs have impacted the entire specialty landscape.

Recent Videos
Naloxone concept represented by wooden letter tiles.
Hand holding a Narcan Evzio Naloxone nasal spray opioid drug overdose prevention medication
Image credit: Gorodenkoff | stock.adobe.com
Pharmacist and Patient in Pharmacy | Image Credit: Gorodenkoff - stock.adobe.com
Sun Screen, Photosensitivity, Pharmacy | Image Credit: sosiukin - stock.adobe.com
Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny - stock.adobe.com
Image Credit: © Anastasiia - stock.adobe.com
Related Content
Image Credit: © eddows - stock.adobe.com

Persistent Epigenetic Changes in Immune Cells Following Hepatitis C Recovery

Alexandra Gerlach, Associate Editor
July 26th 2024
Article
Public Health Matters: Walmart is Elevating Specialty Pharmacy Services and Enriching HIV Care

Public Health Matters: Walmart is Elevating Specialty Pharmacy Services and Enriching HIV Care

July 25th 2024
Podcast
Amyloid plaques forming between neurons

JNJ-2056, Targeting Tau Protein, Receives FDA Fast Track Designation for Alzheimer Disease

Luke Halpern, Assistant Editor
July 26th 2024
Article
Pharmacy Focus: What to Know About Medication and Summer Travel

Pharmacy Focus: What to Know About Medication and Summer Travel

July 12th 2024
Podcast
Biosimilar, Humira | Image Credit: lexiconimages - stock.adobe.com

Patient Affordability Program for Adalimumab Biosimilar Is Launched at GoodRx

Ashley Gallagher, Associate Editor
July 25th 2024
Article
The HIV-AIDS virus visualized.

Twice-Yearly Lenacapavir Effective in Significantly Reducing HIV Infections in Cisgender Women

Luke Halpern, Assistant Editor
July 25th 2024
Article